Novel Ganoderma lucidum IY 034 strain producing large amounts of pharmacologically active glutamate

摘要

The present invention relates to novel ganoderma lucidum strains that produce large amounts of pharmacologically active ingredients. More specifically, the present invention Ganoderma lucidum IY 034, a novel Ganoderma lucidum strain that produces a large amount of high-flavor TTPEN B having anticancer activity, hepatoprotective effect, lipid peroxidation inhibitory activity and antihistamine activity. (KCCM-10066), a method for separating TTPEN B, a pharmacologically active glutamate from this strain, and a TTPEN B isolated by the method.